HSD88 A Practical Approach for the Adoption of the Hub and Spoke Model for Cell and Gene Therapies in Low- and Middle-Income Countries: Framework and Simulation Case Studies

M Toumi,S Tunis,D Ankleshwaria,A Patel,M Diaa,D Trombini,B Kazazoglu Taylor,O Dabbous,S Saleh,S Sullivan

doi:10.1016/j.jval.2023.03.1395

HSD88 A Practical Approach for the Adoption of the Hub and Spoke Model for Cell and Gene Therapies in Low- and Middle-Income Countries: Framework and Simulation Case Studies

M Toumi, S Tunis + Show 8 more

https://doi.org/10.1016/j.jval.2023.03.1395

Copy DOI

Journal: Value in Health

Publication Date: Jun 1, 2023

Affiliation: Aix-Marseille University, Birla Institute of Technology and Science, Pilani - Dubai Campus, Novartis (United States), Novartis (Singapore), Vital Therapies (United States), American University of Beirut, University of Washington

#Cell And Gene Therapies #Low- And Middle-income Countries + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Spurred by biotechnology advances, development of cell and gene therapies (CGTs) is accelerating. As the adoption of CGTs multiply, novel models for CGT delivery are needed, particularly for expanded access in low- and middle-income countries (LMICs). This study proposes and simulates a model for CGT delivery in LMICs and details a framework for the identities and roles of core CGT stakeholders.

Full Text